Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Codexis Completes Tech Transfer to GSK | Contract Pharma

What are you searching for?

Sign in

Codexis Completes Tech Transfer to GSK

Earns $7.5 million milestone for protein engineering platform

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Codexis, Inc., a protein engineering company, has completed the third and final wave in the transfer of its CodeEvolver protein engineering platform technology to GlaxoSmithKline. Codexis expects to receive a $7.5 million payment from GSK for completion of this milestone in 2Q16.
 
“We are delighted to have successfully completed the first full transfer of our CodeEvolver technology platform under a licensing agreement,” said Codexis president and chief executive officer John Nicols. “I am very proud of the successful tech transfer process executed by the Codexis team. They achieved the criteria the parties had set for the tech transfer process, which occurred ahead of schedule.”
 
The agreement grants GSK a license to use Codexis’ CodeEvolver platform technology to develop novel enzymes for use in the manufacture of GSK’s pharmaceutical and health care products. Codexis has the potential to receive additional milestone payments ranging from $5.75 million to $38.5 million per project based on GSK’s successful application of the licensed technology. Codexis is also eligible to receive royalties based on sales for products using Codexis’ CodeEvolver technology.
 
The CodeEvolver platform technology is operational at a GSK R&D facility in PA.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters